Inhibidores de ciclina en primera línea: Eficacia y seguridad en Palbociclib

Previous Page

Next Page

Page Background

Extraído de Rugo HS et al. Breast

Cancer Res Treat. 2019 Jan 10.

PAL + LET

EFS = 40.8 months

PBO + LET

EFS = 29.4 months

Palbociclib + letrozole delayed the time to first subsequent chemotherapy

by 10.5 months